000022784 001__ 22784
000022784 005__ 20210129210832.0
000022784 0247_ $$2pmid$$apmid:22789740
000022784 0247_ $$2DOI$$a10.1016/j.neuroimage.2012.07.001
000022784 0247_ $$2WOS$$aWOS:000308770300046
000022784 0247_ $$2altmetric$$aaltmetric:862460
000022784 037__ $$aPreJuSER-22784
000022784 041__ $$aeng
000022784 082__ $$a610
000022784 084__ $$2WoS$$aNeurosciences
000022784 084__ $$2WoS$$aNeuroimaging
000022784 084__ $$2WoS$$aRadiology, Nuclear Medicine & Medical Imaging
000022784 1001_ $$0P:(DE-HGF)0$$aSavil, M.$$b0
000022784 245__ $$aNormative database of the serotonergic system in healthy subjects using multi-tracer PET
000022784 260__ $$aOrlando, Fla.$$bAcademic Press$$c2012
000022784 300__ $$a447 - 459
000022784 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article
000022784 3367_ $$2DataCite$$aOutput Types/Journal article
000022784 3367_ $$00$$2EndNote$$aJournal Article
000022784 3367_ $$2BibTeX$$aARTICLE
000022784 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000022784 3367_ $$2DRIVER$$aarticle
000022784 440_0 $$04545$$aNeuroImage$$v63$$x1053-8119$$y1
000022784 500__ $$aA. Hahn is recipient of a DOC-fellowship of the Austrian Academy of Sciences at the Department of Psychiatry and Psychotherapy, MUV. The other authors declare no conflict of interest.This research was partly supported by grants from the Austrian National Bank (OeNB13214 to R.L. and OeNB13675 M.M.), the Austrian Science Fund and by an unrestricted investigator-initiated research grant from H. Lundbeck A/S to S.K.A. Hahn is recipient of a DOC-fellowship of the Austrian Academy of Sciences at the Department of Psychiatry and Psychotherapy, MUV.
000022784 520__ $$aThe highly diverse serotonergic system with at least 16 different receptor subtypes is implicated in the pathophysiology of most neuropsychiatric disorders including affective and anxiety disorders, obsessive compulsive disorder, post-traumatic stress disorder, eating disorders, sleep disturbance, attention deficit/hyperactivity disorder, drug addiction, suicidal behavior, schizophrenia, Alzheimer, etc. Alterations of the interplay between various pre- and postsynaptic receptor subtypes might be involved in the pathogenesis of these disorders. However, there is a lack of comprehensive in vivo values using standardized procedures. In the current PET study we quantified 3 receptor subtypes, including the major inhibitory (5-HT(1A) and 5-HT(1B)) and excitatory (5-HT(2A)) receptors, and the transporter (5-HTT) in the brain of healthy human subjects to provide a database of standard values. PET scans were performed on 95 healthy subjects (age=28.0 ± 6.9 years; 59% males) using the selective radioligands [carbonyl-(11)C]WAY-100635, [(11)C]P943, [(18)F]altanserin and [(11)C]DASB, respectively. A standard template in MNI stereotactic space served for region of interest delineation. This template follows two anatomical parcellation schemes: 1) Brodmann areas including 41 regions and 2) AAL (automated anatomical labeling) including 52 regions. Standard values (mean, SD, and range) for each receptor and region are presented. Mean cortical and subcortical binding potential (BP) values were in good agreement with previously published human in vivo and post-mortem data. By means of linear equations, PET binding potentials were translated to post-mortem binding (provided in pmol/g), yielding 5.89 pmol/g (5-HT(1A)), 23.5 pmol/g (5-HT(1B)), 31.44 pmol/g (5-HT(2A)), and 11.33 pmol/g (5-HTT) being equivalent to the BP of 1, respectively. Furthermore, we computed individual voxel-wise maps with BP values and generated average tracer-specific whole-brain binding maps. This knowledge might improve our interpretation of the alterations taking place in the serotonergic system during neuropsychiatric disorders.
000022784 536__ $$0G:(DE-Juel1)FUEK409$$2G:(DE-HGF)$$aFunktion und Dysfunktion des Nervensystems (FUEK409)$$cFUEK409$$x0
000022784 536__ $$0G:(DE-HGF)POF2-89571$$a89571 - Connectivity and Activity (POF2-89571)$$cPOF2-89571$$fPOF II T$$x1
000022784 588__ $$aDataset connected to Web of Science, Pubmed
000022784 65320 $$2Author$$aPET
000022784 65320 $$2Author$$aSerotonin
000022784 65320 $$2Author$$aDatabase
000022784 65320 $$2Author$$a5-HT1A
000022784 65320 $$2Author$$a5-HT2A
000022784 65320 $$2Author$$a5-HT1B
000022784 65320 $$2Author$$a5-HTT
000022784 650_7 $$2WoSType$$aJ
000022784 7001_ $$0P:(DE-Juel1)131672$$aBauer, A.$$b1$$uFZJ
000022784 7001_ $$0P:(DE-HGF)0$$aMitterhauser, M.$$b2
000022784 7001_ $$0P:(DE-HGF)0$$aDing, Y.S.$$b3
000022784 7001_ $$0P:(DE-HGF)0$$aHahn, A.$$b4
000022784 7001_ $$0P:(DE-Juel1)VDB3646$$aKroll, T.$$b5$$uFZJ
000022784 7001_ $$0P:(DE-HGF)0$$aNeumeister, A.$$b6
000022784 7001_ $$0P:(DE-HGF)0$$aHauesler, D.$$b7
000022784 7001_ $$0P:(DE-Juel1)VDB73156$$aet, al$$b8$$uFZJ
000022784 773__ $$0PERI:(DE-600)1471418-8$$a10.1016/j.neuroimage.2012.07.001$$gVol. 63, p. 447 - 459$$p447 - 459$$q63<447 - 459$$tNeuroImage$$v63$$x1053-8119$$y2012
000022784 8567_ $$uhttp://dx.doi.org/10.1016/j.neuroimage.2012.07.001
000022784 909CO $$ooai:juser.fz-juelich.de:22784$$pVDB
000022784 915__ $$0StatID:(DE-HGF)0010$$2StatID$$aJCR/ISI refereed
000022784 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000022784 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000022784 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000022784 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000022784 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000022784 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000022784 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000022784 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000022784 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000022784 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000022784 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000022784 9141_ $$y2012
000022784 9132_ $$0G:(DE-HGF)POF3-571$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vConnectivity and Activity$$x0
000022784 9131_ $$0G:(DE-HGF)POF2-89571$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vConnectivity and Activity$$x1
000022784 9201_ $$0I:(DE-Juel1)INM-2-20090406$$gINM$$kINM-2$$lMolekulare Organisation des Gehirns$$x0
000022784 970__ $$aVDB:(DE-Juel1)139543
000022784 980__ $$aVDB
000022784 980__ $$aConvertedRecord
000022784 980__ $$ajournal
000022784 980__ $$aI:(DE-Juel1)INM-2-20090406
000022784 980__ $$aUNRESTRICTED